发明名称 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CARDIOVASCULAR FIBROSIS
摘要 The present invention relates to methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis. In particular, the present invention relates to an inhibitor of Neutrophil Gelatinase-Associated Lipocalin (NGAL) activity or expression for use in a method for treating or preventing cardiovascular fibrosis in a subject in need thereof.
申请公布号 EP2900245(A1) 申请公布日期 2015.08.05
申请号 EP20130766575 申请日期 2013.09.27
申请人 INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE;UNIVERSITÉ DE LORRAINE;CENTRE HOSPITALIER ET UNIVERSITAIRE DE NANCY (CHU);UNIVERSITÉ PARIS DIDEROT - PARIS 7;UNIVERSITÉ PARIS DESCARTES 发明人 JAISSER, FRÉDÉRIC;FARMAN, NICOLETTE;TARJUS, ANTOINE;ROSSIGNOL, PATRICK;ZANNAD, FAIEZ
分类号 A61K31/7088;A61K31/7105;C12N15/113 主分类号 A61K31/7088
代理机构 代理人
主权项
地址